The aim of abating seizures in a spatio-temporally selective manner is not a modern one. As early as 150 AD, Pelops from Alexandria, the teacher of Galen, was reported to have aborted what would likely be referred to today as 'a simple partial seizure with sensory-motor manifestations' by tying a ligature around the affected limb at the time of the appearance of the first paroxysmal manifestation.
seizure, from the non-seizure content in cortical electrical signals by comparing signal features on two timescales, one short (two seconds), containing ongoing ('foreground') activity, and the other long (30 minutes), containing recent past ('background') activity, which is used as a reference against which the current activity is weighed/quantified. It undertakes two different filtering steps: one discards the non-seizure activity and the other the epileptiform activity that does not qualify as a 'seizure.' There is also a division (yielding a ratio) of the doubly filtered seizure content in the short 'foreground' window by that in the 'background' window. All of the above is carried out with a worthwhile degree of accuracy and speed. The algorithm's design/architecture was guided by three central concepts.
• The raw cortical signals (digitized voltages recorded directly by electrocorticogram (ECoG) from the brains of subjects with pharmacoresistant localization-related ('focal') seizures undergoing invasive surgical evaluation) have time-varying seizure (ictal) and non-seizure (inter-ictal) 'components' that are separable or decomposable (see Figure   1 ) and also quantifiable.
• The separation of seizure from non-seizure activity must be as complete (see Figure 2 ) as is practicable with existing analysis tools (and battery power available to implantable medical devices) to maximize sensitivity, accuracy, and speed of detection of relevant changes.
• Constraints must be imposed on the duration and intensity of changes in the ECoG's seizure content that would be selectable for triggering warnings and delivery of therapy.
Single or brief bursts of epileptiform discharges (EDs) without visible clinical correlates, which are a frequent occurrence in subjects with pharmaco-resistant seizures, may not require warning or treatment and, unless 'ignored' by the algorithm, could trigger unnecessary warnings and treatment.
The decomposition of the ECoG into seizure and non-seizure may be accomplished simply and effectively through the application of spectral filters. A spectral filter, as with any other filter, selectively blocks the 'passage' of irrelevant or undesirable activity. In this application the nonseizure activity in the ECoG is removed using a differential weighting of its frequency content. A reliable and distinctive property of seizures, the sudden and usually marked increases in power relative to the non-seizure state, which in human ECoG typically occur around the 15-35 Hertz frequency range, were exploited for their automated detection. So-called wavelets, 11 which are a robust and highly efficient tool for timefrequency-energy analysis, were used in the algorithm as filters. Among existing wavelet functions, the Daubechies 4, level 3, was selected as the spectral filter because it closely matches the seizures' spectral changes There is the ability to deliver therapy in close temporal proximity to seizure onset and to objectively assess efficacy using not only one (frequency or rate) but three additional relevant variables (intensity, duration, and extent of spread). The results of a clinical trial 5 performed
by these authors will be used to illustrate these benefits in detail.
For this trial, subjects with localization-related, pharmaco-resistant epilepsies were assigned to two groups based on the results of invasive monitoring. One group consisted of four subjects, deemed to be good candidates for resection of epileptogenic tissue (three mesial temporal and one dorsal frontal), to whom high-frequency (>100Hz) charge-balanced square pulses at safe intensities were delivered to the primary epileptogenic zone. The other group comprised four subjects whose seizures originated independently from both mesial temporal regions and were thus inoperable. This group was also treated with highfrequency currents, but these were delivered to the anterior thalamic nuclei, not to the epileptogenic tissue. This trial had two phases: the baseline/control phase, which corresponded to the surgical evaluation phase, and the experimental phase, during which every other seizure was stimulated electrically.
Seizure quantification allows precise assessment of the effects of therapy. Currents at 300Hz (red curve) markedly decrease intensity and duration, whereas those at 50Hz (green curve) increase intensity and duration.
Seizure quantification also uncovers effects of therapy that otherwise are likely to be overlooked. The beneficial effect of electrical stimulation on seizure intensity and duration can outlast its duration ('carry-over' effect), but is less marked than for seizures that are actually stimulated (see also time between seizures, thus increasing their frequency (manuscript in preparation). However, the overall effect is beneficial.
A quantitating detection algorithm also allows investigation of the role that circadian rhythms, seizure interdependencies, and different stimulation parameters have on the severity variables (seizure frequency, intensity, duration, and extent of spread). The influences of seizures on each other ('interdependencies') are being uncovered, 12 and their frequency and intensity show consistent increases at certain times of the day. 13, 14 Development of scalp and extracerebral seizure detection will advance the field even further because its clinical applicability would be broadened beyond that which requires intracranial electrodes. Cardiacbased (EKG) detection 15 is a promising avenue, especially for seizures originating from mesial temporal and insular regions. Once fully developed, extracerebral seizure detection will expand automated detection and logging, warning, and delivery of therapy possibly to nonrefractory subjects.
Quantitative seizure detection also allows in-depth investigation of the spatio-temporal behavior ('dynamics') of experimental and human epilepsies using means for data quantification that were not available before. Although in humans the source of these data is likely to be restricted to subjects with pharmaco-resistant seizures, the dynamic knowledge thus accrued may provide insight into questions of central 
